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Medicine is a learned profession that has its own intrinsic ethic. Under this 
intrinsic ethic, the end of medicine is ordered to a good that is health. 
Technique and conduct are not value-neutral but rather are ordered to this 
overarching good that is the nature-given end of health. Medicine is a 
profession precisely because it professes such a goal. Being a professional 
is more than being a technician. The public profession of medicine as a 
way of life is an affirmation of the moral nature of our activity. Medicine 
as a profession is a public declaration of a willingness to devote oneself to 
others and to serve a higher good. The physician is a moral being who 
professes and affirms the moral nature of his activity. 
We have in recent years seen an attempt to convert our profession 
into a killing activity. Doctors as abortionists kill unbcfm children; doctors 
accept the responsibility to kill patients with or without their consent as in 
Holland, or to engage in the subterfuge of physician-assisted suicide, as in 
the state of Oregon in America. The doctor true to his calling will not 
violate the taboo against killing. He will not do it for love and he will not 
do it for money. 
This is why medicine must be a profession and not merely a 
business. A physician who is guided primarily by the profit motive will 
have conceded that he is willing to sacrifice the best interests of his patient 
in the patient's pursuit of health. 
Recently there has been an erosion of some of the safeguards that 
have accrued to the protection of the patient and the society. 
Let us start with information published in medical journals. This 
information helps to shape diagnostic and therapeutic decisions . For a 
medical journal to be of value, it must publish authoritative, up-to-date 
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information that is free of commercial influence. This requires that the 
financial associations of authors are disclosed and that these associations 
do not influence published articles. This is the only way to avoid bias or 
the appearance of bias based on a conflict of interest. Beyond the authors 
themselves, this freedom from conflict of interest must extend into the 
process of peer review. If those who are assisting the editor in selecting 
articles suitable for publication are not also free from similar financial 
associations, the possibility of bias is reinforced. I Relationships between 
biomedical companies and research are growing rapidly. Beyond the direct 
support of research or therapeutic trials, authors may receive consulting 
fees, serve on advisory boards, own equity, receive patent royalties or 
receive honoraria for lectures or expert testimony. 
Recently the New England Journal of Medicine2 and, by inference3 
the Journal of the American Medical Association, have altered their 
policies so that authors of original articles as well as review atticles and 
editorials will not have any "significant" financial interest in a company (or 
its competitors) that makes a product discussed in an article. The National 
Institutes of Health4 and the Association of American Medical Colleges5 
have likewise relaxed their requirements regarding financial association 
and resultant possible bias. The attempt has been made to quantitate what 
degree of association could produce bias. The key provision is to set an 
upper limit on the annual sum received by an author in order to have a 
relationship considered "significant." Currently $10,000 is the de minimus 
level. Beyond this, any holding in which the potential for profit is not 
limited, such as stock, stock options or patent holdings, would probably be 
disqualifying. 
The justification for these changes in policy is said to be an inability 
to impanel an adequate number of authors and/or reviewers to carry out the 
functions of the journal because so many academicians ~nd clinicians are 
involved in intertangling financial relationships with pharmaceutical 
companies.5•6 
Inevitably the outcome of the policy will be an enhanced opportunity 
for the introduction of conflict of interest and a reduced confidence in the 
reliability of published data. This will extend not only to decision making 
by physicians and researchers but also to the general public. Almost every 
major media outlet in the United States has a science editor and staff that 
cover current medical literature, often counting on summaries and releases 
published for their edification by the journals themselves. Providing this 
service is a large source of income, for example, to the American Medical 
Association. 
Let us take one example. An article in the New England Journal on 
RU-486 (Silvestre L. et al. New Eng J Med 322:645, 1990) concluded that 
RU-486 was "effective and safe." Those who thought the data to be 
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excessively sanguine and reassuring could be forewarned by the revelation 
in a prominent place that all six authors were employees of Roussel-Uclef, 
which manufactured RU-486 and stood to make huge profits from sales. 
The knowledge that the so-called "scientific" article was in fact an ill-
disguised promotional piece could result in a healthy cynkism on the part 
of readers. Not only was the unfounded enthusiasm promoted as factual by 
the manufacturer, but also by the entire publicity apparatus of the pro-
abortion lobby and its media collaborationists. 
Concerns Regarding Bias 
A delegation from the Catholic Medical Association met with the 
executive director and the editorial staff of the lAMA to express our 
concern that during the previous three years approximately fifteen pro-
abortion articles were published and not one anti-abortion paper. Editorial 
bias was vehemently denied. Subsequently, however, we came into 
possession of an internal memorandum7 leaked to us by an AMA employee 
informing the editorial staff of lAMA that, in fact, their policy was as 
demonstrated, that is, not to publish anti-abortion studies or statistical 
studies unfavorable to abortion. 
If this ideological bias is now to be augmented by a potential for bias 
based on economic gain, the profession and the public will have been 
thoroughly compromised. 
President Bush was recently called upon to make a Solomonic 
decision regarding stem cell research. While by no means a perfect 
decision, it did make the important distinction between embryonic stem 
cells (produced from embryos created for the purpose of being killed to 
harvest their stem cells) and stem cells produced from adult sources , 
(umbilical cord blood, bone marrow, etc.). While forbidding federal 
funding of the creation of any new embryonic stem cell lines the president 
did concede, in his policy, the continuation of existing cell lines from 
embryos. These were the fruit of a poisoned tree and, since adult stem cells 
had outperformed embryonic stem cells both clinically and in the 
laboratory, it was difficult to comprehend the dogmatic insistence by the 
scientific community of the superiority of and need for embryonic cell 
lines. 
It turned out that many of the existing embryonic cell lines that were 
allowed to be preserved were in fact owned by universities and other 
enterprises that had every intention of profiting from the propagation of 
and distribution of embryonic stem cells for research. 
During the debate on cloning8 in the U.S. Congress, it was revealed 
that three human cloning patents were pending in the U.S. patent office. 
The sponsor of the Human Cloning Prohibition Act, Senator Brownback, 
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pointed out that the notion that we have to kill one person in order to find a 
cure for another is a false tradeoff which disregards advances made in other 
non-embryonic stem cell sources. Even more frightening is the prospect of 
people in corporate America owning, trading, buying, and selling people 
(clones) as if they were property. This is an issue that must be included in 
the cloning debate. When Senator Brownback introduced a Human 
Unpatentability Amendment to outlaw patenting human clones, it was 
defeated.9 This occurred on the same day that a team from the University 
of Minnesota reported on the versatility of adult stem cells and their ability 
to convert and morph into hundreds of specialized cells within the body. 10 
Jonathan Swift said, "Falsehood flies and the truth comes lingering 
after, so that when men come to be undeceived the jest is over and the tale 
has had its effect." The culture of death has for the last thirty years clearly 
controlled the press and the media now shows a sinister proclivity toward 
controlling the scientific literature and thereby the political process. 
Through the powerful incentive of the profit motive derives the clear 
conflict of interest between objective scientific investigation and advocate 
science in pursuit of monetary gain. 
The ultimate perversion of the commercialism of medical research 
would be the sale of body parts for use in experimentation. The reality of a 
brisk business in fetal body parts has been exposed by numerous 
investigative pro-life agencies . This offshoot of the abortion industry has 
been demonstrated to advertise the availability of organs from aborted 
babies in scientific journals. These are not merely allegations but are truly 
undeniable since actual advertisements containing price lists for human 
tissues have been exposed. Such offerings as "fetal liver, second trimester 
fetal kidney, pancreatic islet tissue," each with an attached price list have 
been discovered, (having been placed by so-called laboratories doing 
business with abortionist sources.). I I • 
A movement is currently underway to approve the payment by 
potential recipients for donor organs. Currently the National Organ 
Transplant Act makes it illegal for "any person to knowingly acquire, 
receive or otherwise transfer any human organ for valuable consideration 
for use in human transplantation." The American Medical Association has 
called for a study of the possibility of paying donors for organs. 12 The 
background for this consideration of a radical policy change is, of course, 
the annual shortfall in the availability of donor organs. The United 
Network for Organ Sharing database indicates that there are now 75,000 
patients waiting for an organ. Among those waiting for a heart or liver 
transplant one-third will die before an organ becomes available. 
The primary source of donor organs will be the so-called Heart 
Beating Cadaver Donors. These are patients who have had an irreversible 
cessation of total brain function and are being maintained on ventilators in 
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intensive care units . These will constitute a pool of 10,000-12,000 potential 
donors per year. Despite extensive public awareness campaigns, the ratio 
of actual to potential donors has not increased sufficiently. 13 One response 
has been a greater reliance on living donors (kidneys), partial transplants 
(liver and lungs) and sources of dubious ethical propriety such as 
anencephalic infants and animals . 14 
Another potential source of transplantable organs is patients who 
have been declared dead by traditional cardiopulmonary rather than brain-
based criteria. The success of transplants using organs from these sources 
has been limited by problems with warm ischemia. These non-Heart 
Beating Cadaver Donors fall generally into two categories: 1) 
Uncontrolled Cardio-Pulmonary Death (usually in emergency rooms) and 
2) Controlled Timing and Place of Death. This second category follows a 
method commonly known as the Pittsburgh protocol. 15 
Under this protocol, families who have decided to forego life support 
are approached to donate organs. Warm ischemia time is minimized by 
taking the patient to the operating room, disconnecting life support there, 
and removing organs immediately or shortly after the pronouncement of 
death. Ethical issues surrounding the use of Non-Heart Beating Cadaver 
Donors have to do with the consent process, the question of irreversibility 
and early declaration of death. There are also intuitive problems related to 
the fact that the procedure seems staged or contrived in that the patient is 
declared dead after having been removed from the company of his near 
relatives and into an operating room. 
Market forces have begun to erode the standard of uncompensated 
donation from living donors by the opportunity to obtain organs outside the 
United States. AmeIicans are purchasing organs from strangers in China, 
Peru, and the Philippines and then returning to the U.S. for post-
transplantation care. 16 ' 
Another challenge to the altruistic principles underlying the Act is 
the increased frequency of kidney donations by patients unrelated to the 
recipients since a close genetic match is no longer as necessary. The 
possibility exists of illegal purchase and illegal profits beyond the control 
of transplantation centers. 17 
The movement to liberalize the rules to allow for a freer market in 
the purchase of organs raises the specter of a bidding war in which less 
deserving wealthy candidates for transplantation gain priority over poor 
candidates lacking the wherewithal to purchase organs. One economist has 
suggested that less affluent individuals could always take out loans to 
purchase organs as they now do to purchase automobiles or houses. What 
happens, however, if the borrower is incapable of repaying the loan? Can 
we have some mechanism for foreclosing on or repossessing a kidney? 
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The present system of providing ethical or humanitarian incentives 
for donation would protect the unbiased distribution of organs based on 
priority of need.!S 
Brokering criteria in the United States would be impossible to 
control. If the current prohibition against the sale of organs were 
rescinded, there would be no legal justification for preventing persons from 
bypassing the regulated system to compete in an unregulated market. The 
potential unfairness of such a market and the preferability of enhanced 
ethical incentives (public recognition, compensation of funeral expenses or 
tax credits) would be the better way to sustain broad societal interest.!9 
Bioterrorism 
Finally, a world of bioterrorism, a fundamental conflict of interest 
has arisen over the issue of whether biologists should publish work that 
could be rnisused. The National Academy of Sciences has set up a panel to 
study how to prevent the destructive applications of advanced 
biotechnology.20 Recent studies on the 1918 pandemic influenza virus at 
the Armed Forces Institute of Pathology have suggested the potentials for 
reconstructing the 1918 virus and making it more resistant to the immune 
system.2! Similar studies have been published to demonstrate how to 
engineer microorganisms to spread more readily, resist antibiotics and 
vaccines and thus be more effective as weapons for bioterrorism. There are 
serious questions as to whether such information should be made available 
in journals. A conflict of interest has arisen between bioweapons experts in 
the government and the American Society of Microbiology as to whether 
there should be special peer review. Needless to say, scientists are highly 
resistant to the notion that their work or any importan, data should be 
subject to censure for political reasons. 
Though the conflicts of interest may not be as demonstrable in a 
socialized medical system as they are in a capitalist system, they are 
unavoidable in a privately based system either fee for service or managed 
care. The main protection against the intrusion of political and economic 
issues into medical care is a return to the Hippocratic system of medical 
ethics that remains viable in all cultures and all forms of reimbursement. 
Finally, another opportunity for conflict of interest consists of so-
called "advocate science." This consists in the propounding of so-called 
"scientific" claims or rejecting counterclaims based not on the quality of 
objective data involved but rather on a hidden political agenda or a desire 
for political correctness. 
The principal occasion for the employment of advocate science is in 
research regarding the etiology and the treatment of homosexuality or 
same-sex attraction disorder. The media have promoted the idea that a 
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"gay gene" has already been discovered and certain professional 
organizations have not discouraged this assumption. If same sex attraction 
were genetically determined, then one could expect identical twins to be 
identical in their sexual attractions. Most studies, however, show that 
identical twins are discordant in their sexual attraction.22, 23, 24 
There are, however, ongoing attempts to convince the public that 
same sex attraction is genetically based. Such attempts are politically 
motivated by the supposition that the public would be more likely to 
respond to changes in laws and religious teaching were they to believe that 
same sex attraction is genetically determined and unchangeable. 
A similar controversy surrounds the issue as to whether the 
homosexual state is treatable and changeable. In the debate between 
essentialism and social constructionism, the believer in natural law would 
hold that human beings have an essential nature - either male or female -
and that sinful inclinations such as the desire to engage in homosexual acts 
are constructed and can, therefore, be deconstructed. Some members of 
the American Psychiatric Association have gone so far as to allege that 
attempts to change homosexuals are not only unsuccessful but even 
unethical. There are a number of therapists however, who have written 
extensively that reparative therapy is successful with about 30% 
experiencing a freedom from same sex attraction and another 30% 
improvement.25, 26. 27, 28 Dr. Robert Spitzer, the renowned Columbia 
University psychiatric researcher, who was largely responsible for the 
removal of homosexuality from the APA's list of mental disorders, has now 
indicated that his most recent research indicates that sustained change can 
be achieved.29 
Other examples of advocate science would include, fIrst, the 
American Cancer Society 's refusal to admit a relf1tionship between 
abortion and breast cancer,30 despite overwhelming evidence and, second, 
the insistence of the National Institutes of Health on the effectiveness of the 
condom in preventing AIDS. When the question was posed at a large 
international meeting of AIDS experts as to how many would be willing to 
have sexual intercourse with an HIV positive person while wearing a 
condom, no one in the audience raised their hand.31 The evidence strongly 
suggested that the officialdom of numerous professional organizations, 
such as AMA and American College of Obstetrics and Gynecology, has a 
hidden agenda of apologizing for abortion and upholding the homosexual 
rights lobby despite any evidence to the contrary and despite the 
conflicting opinion of many in their grass roots membership. 
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